Literature DB >> 1566356

Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but with a qualitative change in the cytotoxic T cells recognizing the same antigen.

D Roelen1, G Datema, S van Bree, L Zhang, J van Rood, F Claas.   

Abstract

Previous studies in highly sensitized patients waiting for a renal transplant, showed a lack of correlation between the B cell and T cell allorepertoire. The cytotoxic T cell precursor (CTLp) frequencies against HLA-antigens, toward which patients had formed antibodies (not-acceptable mismatches, NAM) were similar to those against HLA antigens, toward which no antibodies were present (acceptable mismatches, AM). In the present study we have tested whether the immunological triggering leading to antibody formation might have resulted in a different population of cytotoxic T cells. Limiting dilution assays performed in the absence or presence of antibodies against CD8 showed that CTL directed against NAM were significantly less inhibited by anti-CD8 compared to AM. A possible clinical relevance of these findings is suggested by experiments showing that the CTL against NAM were also more resistant to cyclosporine than CTL against AM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1566356     DOI: 10.1097/00007890-199204000-00035

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects.

Authors:  V A L Huurman; C R van der Torren; P Gillard; R Hilbrands; E P M W van der Meer-Prins; G Duinkerken; F K Gorus; F H J Claas; B Keymeulen; D L Roelen; D G Pipeleers; B O Roep
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

2.  Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.

Authors:  D L Roelen; V A L Huurman; R Hilbrands; P Gillard; G Duinkerken; P W M van der Meer-Prins; M F J Versteeg-van der Voort Maarschalk; C Mathieu; B Keymeulen; D G Pipeleers; B O Roep; F H J Claas
Journal:  Clin Exp Immunol       Date:  2009-01-21       Impact factor: 4.330

3.  Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia.

Authors:  L M Faber; S A van Luxemburg-Heijs; R Willemze; J H Falkenburg
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.